Telehealth abortion remains available for now, after a judge’s ruling : NPR

Key Points:

• A federal judge in Louisiana granted a temporary hold on a case challenging the FDA's 2023 rule allowing telehealth prescriptions of mifepristone, a widely used abortion medication, pending the FDA's ongoing safety review.
• The ruling acknowledges Louisiana's concerns about telemedicine abortion but defers to the FDA's expertise on public health decisions, ordering the agency to update the court in six months.
• The case highlights divisions among Republicans, with some pushing for stricter abortion drug restrictions while others, including former President Trump, have shown more nuanced positions on abortion policy.
• Louisiana is aggressively pursuing anti-abortion measures, including scheduling mifepristone as a controlled substance and criminally indicting out-of-state telemedicine providers, reflecting a strategic shift after earlier legal setbacks.
• Despite abortion restrictions and bans, abortions continue at similar rates nationwide, with telemedicine access to abortion drugs providing critical options for patients in restrictive states like Louisiana.